These organizations can and will adapt. But as I said in my OP, the real, lasting damage is in prestige. In the meantime, scientists all over the world thinking about working in the US will think twice. Young adults thinking about becoming research physicians and doing biomedical research will think twice. Researchers making peanuts working at universities doing this research will go work in pharma on more lucrative projects.